From OpenWetWare
Jump to navigationJump to search

PR Newswire: "Stony Brook Study on the Role of DNA Amplification in Cancer Chemoresistance Leverages KromaTiD dGH in-Site™ Technology" [1]

Stony Brook News: "Turning Drug Resistance Against Itself" [2]

Stony Brook News: "Rethinking the Protein Inhibitor Approach to Cancer Therapy" [3]

Stony Brook News: "Study Offers New Approach to Combating Drug Resistance" [4]

Oxford Global [5] interview on combining synthetic gene circuits and genome editing [6]

Stony Brook News: Study Shows Evolution Turns Genes Back On to Regain Function [7]

Stony Brook News: Engineered Cell Evolution May Provide Pathway to Halting Cancer Drug Resistance [8]

Back to the main page: CHIP